Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Pediatr ; 19(1): 200, 2019 06 17.
Article in English | MEDLINE | ID: mdl-31208399

ABSTRACT

BACKGROUND: Noma is a rare disease, which is characterized by rapid progression and a high rate of mortality; however, relatively few cases of noma infection accompanied by septic shock in children have been described. Further, most health care professionals have no knowledge of this disease or of its clinical significance. CASE PRESENTATION: Herein, we present a case report of a six-year-old male patient who was diagnosed with noma infection at a Chinese pediatric medical intensive care unit (PMICU), at which time, it was discovered that he had septic shock. Following treatment by continuous renal replacement therapy (CRRT) for septic shock arising from noma, the patient was in generally good condition, and the local wound was seen to be essentially healed five weeks post-admission. CONCLUSION: Noma is an opportunistic infectious disease condition. Treatment of the acute phase of noma predominantly focuses on controlling the infection and improving systemic conditions. In addition, CRRT could be considered as a treatment option for cases that present with noma accompanied by septic shock.


Subject(s)
Noma/complications , Renal Replacement Therapy , Shock, Septic/etiology , Shock, Septic/therapy , Child , Humans , Intensive Care Units, Pediatric , Male , Noma/blood , Noma/pathology , Photography , Shock, Septic/blood
2.
Lancet Glob Health ; 1(2): e87-e96, 2013 Aug.
Article in English | MEDLINE | ID: mdl-25104163

ABSTRACT

BACKGROUND: Noma is a poorly studied disease that leads to severe facial tissue destruction in children in developing countries, but the cause remains unknown. We aimed to identify the epidemiological and microbiological risk factors associated with noma disease. METHODS: We did a prospective, matched, case-control study in Niger between Aug 1, 2001, and Oct 31, 2006, in children younger than 12 years to assess risk factors for acute noma. All acute noma cases were included and four controls for each case were matched by age and home village. Epidemiological and clinical data were obtained at study inclusion. We undertook matched-paired analyses with conditional logistic regression models. FINDINGS: We included 82 cases and 327 controls. Independent risk factors associated with noma were: severe stunting (odds ratio [OR] 4·87, 95% CI 2·35-10·09) or wasting (2·45, 1·25-4·83); a high number of previous pregnancies in the mother (1·16, 1·04-1·31); the presence of respiratory disease, diarrhoea, or fever in the past 3 months (2·70, 1·35-5·40); and the absence of chickens at home (1·90, 0·93-3·88). After inclusion of microbiological data, a reduced proportion of Fusobacterium (4·63, 1·61-13·35), Capnocytophaga (3·69, 1·48-9·17), Neisseria (3·24, 1·10-9·55), and Spirochaeta in the mouth (7·77, 2·12-28·42), and an increased proportion of Prevotella (2·53, 1·07-5·98), were associated with noma. We identified no specific single bacterial or viral pathogen in cases. INTERPRETATION: Noma is associated with indicators of severe poverty and altered oral microbiota. The predominance of specific bacterial commensals is indicative of a modification of the oral microbiota associated with reduced bacterial diversity. FUNDING: Gertrude Hirzel Foundation.


Subject(s)
Birth Order , Microbiota/genetics , Mouth/microbiology , Noma/epidemiology , Poverty/statistics & numerical data , RNA, Ribosomal, 16S/genetics , Capnocytophaga/genetics , Capnocytophaga/isolation & purification , Case-Control Studies , Child , Child, Preschool , Diarrhea/epidemiology , Family Characteristics , Female , Fever/epidemiology , Fusobacterium/genetics , Fusobacterium/isolation & purification , Growth Disorders/epidemiology , Humans , Infant , Male , Neisseria/genetics , Neisseria/isolation & purification , Niger/epidemiology , Noma/blood , Noma/microbiology , Prevotella/genetics , Prevotella/isolation & purification , Prospective Studies , Respiratory Tract Diseases/epidemiology , Risk Factors , Spirochaeta/genetics , Spirochaeta/isolation & purification , Vitamin A/blood , Wasting Syndrome/epidemiology , alpha-Tocopherol/blood
3.
J Med Primatol ; 37(5): 217-22, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18822072

ABSTRACT

BACKGROUND: A Japanese monkey developed severe oro-facial lesions that were called noma in humans. Although extensive destruction of both the buccal regions occurred with rapid progress, author successfully treated the lesions with povidone-iodine, enrofloxacin, chymotrypsin, a glycyrrhizin preparation, and a basic fibroblast growth factor. METHODS: Author clinicopathologically investigated this disease during the treatment. RESULTS: In the subcutaneous and muscular tissues, the lesions developed characteristic changes such as dissolving collagen fibers and muscular tissues phagocytosed by giant and epitheloid cells. The monkey showed a notable increase in creatine kinase activities. The present examinations revealed severe invasive findings in muscular tissues, which were accompanied by infections of beta-hemolytic streptococcus Group C. This monkey was negative for simian immunodeficiency virus antibody; however, infection with simian D retrovirus was not ruled out. CONCLUSIONS: Simian noma was a rapidly devastating disease, which destroyed the muscle tissues of oro-facial structure. Nonhuman primates are the only species that develop oro-facial lesions, corresponding to noma in humans.


Subject(s)
Macaca/microbiology , Monkey Diseases/pathology , Noma/veterinary , Animals , Blood Cell Count , Face/microbiology , Face/pathology , Female , Male , Monkey Diseases/blood , Monkey Diseases/drug therapy , Monkey Diseases/microbiology , Noma/blood , Noma/drug therapy , Noma/microbiology , Noma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...